Insider Trading

SANA Stock  USD 2.15  0.27  11.16%   
About 64% of Sana Biotechnology's investor base is looking to short. The analysis of the overall investor sentiment regarding Sana Biotechnology suggests that many traders are alarmed. The current market sentiment, together with Sana Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Sana Biotechnology stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Sana Biotechnology Officer: See Remarks. Insider Public Trading

Read at macroaxis.com
Sana insider trading alert for general transaction of restricted stock units by Susan Wyrick, Officer: See Remarks, on 4th of October 2024. This event was filed by Sana Biotechnology with SEC on 2024-10-04. Initial filing of beneficial ownership - SEC Form 3

Cash Flow Correlation

Sana Biotechnology's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Sana Biotechnology's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Sana Biotechnology Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Sana Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Sana Biotechnology Historical Investor Sentiment

Investor biases related to Sana Biotechnology's public news can be used to forecast risks associated with an investment in Sana. The trend in average sentiment can be used to explain how an investor holding Sana can time the market purely based on public headlines and social activities around Sana Biotechnology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Sana Biotechnology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Sana Biotechnology and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Sana Biotechnology news discussions. The higher the estimate score, the more favorable the investor's outlook on Sana Biotechnology.

Sana Biotechnology Fundamental Analysis

We analyze Sana Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sana Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sana Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Sana Biotechnology is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Sana Biotechnology Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sana Biotechnology stock to make a market-neutral strategy. Peer analysis of Sana Biotechnology could also be used in its relative valuation, which is a method of valuing Sana Biotechnology by comparing valuation metrics with similar companies.

Peers

Sana Biotechnology Related Equities

AMLXAmylyx Pharmaceuticals   3.56   
0%
26.0%
HOOKHookipa Pharma   1.65   
0%
12.0%
DAWNDay One   0.97   
0%
7.0%
APLSApellis Pharmaceuticals   2.06   
15.0%
0%
RVMDRevolution Medicines   2.26   
16.0%
0%
BPMCBlueprint Medicines   2.30   
17.0%
0%
GLUEMonte Rosa   2.74   
20.0%
0%
CGEMCullinan Oncology   2.81   
21.0%
0%
OLMAOlema Pharmaceuticals   3.01   
22.0%
0%
LYELLyell Immunopharma   5.36   
40.0%
0%
TERNTerns Pharmaceuticals   5.41   
40.0%
0%
ZNTLZentalis Pharmaceuticals   5.56   
41.0%
0%
KYMRKymera Therapeutics   5.58   
41.0%
0%
GBIOGeneration Bio   6.00   
45.0%
0%
NKTXNkarta   7.74   
58.0%
0%
XFORX4 Pharmaceuticals   13.33   
100.0%
0%

Complementary Tools for Sana Stock analysis

When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital